Operating Expenses
Medtronic·Income Statement·9 metrics
Breakdown
| Metric | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Selling, general and administrative | $2.7B | $2.8B | $2.7B | $2.7B | $2.8B | $3B | $3B | $3.1B |
| Depreciation and amortization | $662M | $675M | $684M | $840M | $748M | $745M | $749M | $716M |
| Research and development | $676M | $697M | $675M | $684M | $726M | $754M | $722M | $671M |
| Other operating expenses | -$1M | $34M | $5M | — | -$70M | -$22M | -$35M | -$260M |
| Litigation provision | $79.3M | $79.3M | $79.3M | $79.3M | $28.3M | $28.3M | $28.3M | $28.3M |
| Goodwill impairment | $0 | $0 | $0 | — | $0 | $0 | $0 | — |
| Impairment charges | $0 | $0 | $0 | — | $0 | $0 | $0 | — |
| Provision for credit losses | $18M | $27M | $51M | — | $28M | $38M | $36M | — |
| Restructuring charges | $62M | $46M | $46M | — | $67M | $13M | $172M | — |